Rajat Deo, MD
Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
Penn Medicine Provider

About me

  • Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: University of Michigan
  • Residency: University of Texas Southwestern Medical Center
  • Fellowship: UCSF Medical Center and Hospital
  • Fellowship: Johns Hopkins Hospital

What my patients think about me

Average Rating

204 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
explanation was clear
October 2025
easy to talk to and very informative
October 2025
very professional and took me at my appointment right on time
September 2025
dr deo is a superstar

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Deo is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Rekapalli P, Oraii A, Heintz J, Dixit S, Epstein AE, Frankel DS, Hyman M, Lin D, Markman T, Messé SR, Nazarian S, Cucchiara B, Schaller RD, See VY, Yang W, Kasner SE, Marchlinski FE, Deo R. Detection and Significance of Nonsustained Ventricular Tachycardia in a Post-Stroke Population , JACC Clin Electrophysiol: 2025


Sedaghat S, Park S, Walker RF, Wang S, Liu J, Hughes TM, Sabayan B, Tang W, Coresh J, Pankow JS, Walker KA, Casanova R, Dubin R, Deo R, Rotter JI, Wood AC, Ganz P, Lutsey PL, Guan W, Prizment A. Proteomics-based aging clocks in midlife or late-life and their associated risk of dementia , Commun Med (Lond), 5: 2025,353


Kim YG, Nam Y, Westbrook TM, Joo J, Woerner J, Deo R, Ritchie MD, Kim D. Protein risk scores enable precise prediction of cardiovascular events in chronic kidney disease patients , medRxiv: 2025


Enriquez A, Yogasundaram H, Neira V, Guandalini G, Markman T, Shivamurthy P, Hyman M, Hanumanthu B, Lin D, Schaller R, Supple G, Dixit S, Deo R, Nazarian S, Kumareswaran R, Riley M, Epstein AE, See V, Zado E, Callans D, Frankel D, Marchlinski F, Garcia F. Stepwise Anatomical Approach to Ablation of Intramural Outflow Tract Ventricular Arrhythmias Guided by Septal Coronary Venous Mapping , Circulation, 152: 2025,163-171


Guzman DE, Ruvuna L, Guo CJ, Sun Y, Pratte KA, Manichaikul AW, Kim JS, Post WS, Bertoni AG, Allen NB, Watson KE, Pankow JS, Hoffman EA, Dubin RF, Deo R, Barjaktarevic IZ, Bleecker ER, Cooper CB, Ortega VE, Hastie AT, Paine R 3rd, Wells JM, Curtis JL, Silverman EK, Woodruff PG, Garcia CK, Rotter JI, Bowler RP, Ganz P, Barr RG. Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung Study , Respir Res, 26: 2025,236


Woerner J, Westbrook TM, Joo J, Shivakumar M, Venkatesh R, Cherlin T, Jung SH, Jeong S, Maseda D, McKeague M, Shwetank, Ionita M, Wagenaar J, Abramowitz SA, Verma A, Zhao B, Lee S, Damrauer S, Levin MG, Heo SC, Cappola TP, Rader DJ, Day S, Deo R, Gelfand JM, Ramessur R, Guerraty MA, Setia-Verma S, Pasaniuc B, Ritchie MD, Apostolidis SA, Greenplate AR, Wherry EJ; Penn Medicine Biobank; Nam Y, Kim D. Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction , medRxiv: 2025


Zhou J, Williams C, Staplin N, Judge PK, Mayne KJ, Agrawal N, Arimoto R, Green JB, Cherney DZI, Tuttle KR, Leal J, Clarke P, Emberson JR, Preiss D, Wanner C, Landray MJ, Baigent C, Haynes R, Herrington WG, Mihaylova B; EMPA-KIDNEY Collaborative Group. Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial , EClinicalMedicine, 85: 2025,103338


Greenberg JH, Abraham AG, Xu Y, Schelling JR, Coca SG, Schrauben SJ, Wilson FP, Waikar SS, Vasan RS, Gutiérrez OM, Shlipak MG, Ix JH, Warady BA, Kimmel PL, Bonventre JV, Parikh CR, Denburg M, Furth S; CKD Biomarkers Consortium. Biomarker Panels for Discriminating Risk of CKD Progression in Children , J Am Soc Nephrol, 36: 2025,1105-1115


Tamargo CL, Coca SG, Thiessen Philbrook H, Hu DG, Ix JH, Shlipak MG, Fried LF, Gutierrez OM, Waikar SS, Schrauben SJ, Schelling JR, Ganz P, Kimmel PL, Greenberg JH, Deo R, Takakura A, Vasan RS, Bonventre JV, Parikh CR. The distal nephron biomarkers associate with diabetic kidney disease progression , JCI Insight, 10: 2025,e186836


Lopez-Silva C, Surapaneni A, Coresh J, Chen TK, Schlosser P, Rhee EP, Waikar SS, Schmidt IM, Deo R, Ganz P, Dubin R, Ramachandran VS, Kimmel PL, Schrauben SJ, Parikh CR, Bonventre JV, Dobre M, Rao PS, Ricardo AC, Weir MR, Grams ME; CRIC Study Investigators. Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts , Am J Nephrol: 2025


View all publications